» Articles » PMID: 15771579

Antigen-specific Memory B Cell Development

Overview
Date 2005 Mar 18
PMID 15771579
Citations 300
Authors
Affiliations
Soon will be listed here.
Abstract

Helper T (Th) cell-regulated B cell immunity progresses in an ordered cascade of cellular development that culminates in the production of antigen-specific memory B cells. The recognition of peptide MHC class II complexes on activated antigen-presenting cells is critical for effective Th cell selection, clonal expansion, and effector Th cell function development (Phase I). Cognate effector Th cell-B cell interactions then promote the development of either short-lived plasma cells (PCs) or germinal centers (GCs) (Phase II). These GCs expand, diversify, and select high-affinity variants of antigen-specific B cells for entry into the long-lived memory B cell compartment (Phase III). Upon antigen rechallenge, memory B cells rapidly expand and differentiate into PCs under the cognate control of memory Th cells (Phase IV). We review the cellular and molecular regulators of this dynamic process with emphasis on the multiple memory B cell fates that develop in vivo.

Citing Articles

Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report.

Martin M, Tay C, Siew T Toxins (Basel). 2024; 16(10).

PMID: 39453199 PMC: 11510976. DOI: 10.3390/toxins16100422.


Phenotypic Characterization of B-Lymphocyte Subpopulations in Human Peripheral Blood: A Cost-Effective Seven-Color One-Tube Protocol.

Pinto T, Benard G, Fernandes J Methods Mol Biol. 2024; 2857:15-31.

PMID: 39348052 DOI: 10.1007/978-1-0716-4128-6_3.


Peripheral Blood Lymphocyte Subsets in Factor VIII Inhibitor-Positive Patients with Severe Hemophilia A: A Case-Control Study.

Zhao L, Zhang Y, Guo X, Li Z, Lu W, Pan Z Clin Appl Thromb Hemost. 2024; 30:10760296241268421.

PMID: 39149981 PMC: 11329969. DOI: 10.1177/10760296241268421.


Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity.

Dennis E, Murach M, Blackburn C, Marshall M, Root K, Pattarabanjird T Front Immunol. 2024; 15:1380641.

PMID: 38601144 PMC: 11004297. DOI: 10.3389/fimmu.2024.1380641.


Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function.

Liu Y, Ren S, Ma L, Lin X, Lu J, Cao Z Virol J. 2024; 21(1):77.

PMID: 38555445 PMC: 10981809. DOI: 10.1186/s12985-024-02344-8.